This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


  • "New" Human Adenovirus May Not Make for Good Vaccines, After All
    In a new study of four adenovirus vectors, researchers from the Wistar Institute show that a reportedly rare human adenovirus, called AdHu26, is not so rare, after all, and would thus be unlikely to be optimal as a vaccine carrier for mass vaccination. ...More
    August 11, 2010 Posted in News
  • Infectious Disease Specialist Addresses Rise of the Superbugs
    People all over the world are getting sick and dying of an incurable plague. Hospitals are inundated. And there is no cure in sight. It sounds like the plot to a far-fetched futuristic sci-fi movie, right? The bad news is it’s not, according to Brad Spellberg, MD, associate ...More
    August 11, 2010 Posted in News
  • Joint Venture to Develop Broad-Spectrum Pandemic Flu Vaccine
    Temasek Life Science Ventures Pte Ltd (TLV) and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused ...More
    August 11, 2010 Posted in News
  • Mobile Messaging Could be a Viable New Surveillance Tool
    In the September 2010 issue of Emerging Infectious Diseases, CDC's monthly peer-reviewed journal, Martin Lajous, of the department of epidemiology at Harvard School of Public Health, describes how mobile messaging was used as a surveillance tool during the H1N1 influenza ...More
    August 11, 2010 Posted in News
  • Research Project to Define Markers of Human Immune Responses to Infection and Vaccination
    A new nationwide research initiative has been launched to define changes in the human immune system, using human and not animal studies, in response to infection or to vaccination. Six U.S.-based Human Immune Phenotyping Centers will receive a total of $100 million over ...More
    August 11, 2010 Posted in News
  • Researchers Warn of Potential New Superbug
    A study appearing in the Aug. 11 issue of Lancet Infectious Diseases indicates that a new gene, NDM-1, is creating resistance in bacteria to almost all known antibiotics, including carbapenems, and there are no new drugs in the pipeline to combat a potential new superbug. ...More
    August 11, 2010 Posted in News
  • SPSmedical Provides "Green" Solutions for the SPD
    SPSmedical, a leading supplier of sterility assurance products, announces that it is dedicated to reducing its environmental impact and providing "green" solutions for the sterile processing department. SPSmedical reports that it has successfully reduced its packaging, ...More
    August 10, 2010 Posted in News, Disinfection & Sterilization
  • Foodborne Transmission of Clostridium difficile
    Two researchers from the CDC report on the emerging issue of Clostridium difficile transmission via food in the community setting. ...More
    August 10, 2010 Posted in News
  • Rates of Healthcare-Associated MRSA Infections Decreasing
    An analysis of data from 2005 through 2008 of nine metropolitan areas in the U.S. indicates that healthcare-associated invasive methicillin-resistant Staphylococcus aureus (MRSA) infections decreased among patients with infections that began in the community or in the ...More
    August 10, 2010 Posted in News
  • WHO Announces H1N1 is in Post-Pandemic Period
    Margaret Chan, head of the World Health Organization (WHO) and members of its Emergency Committee, have declared that H1N1 influenza has entered a post-pandemic period. According to Chan, the committee based its assessment on the global situation, as well as reports from ...More
    August 10, 2010 Posted in News